Brief: Zealand Pharma And OTR Therapeutics Enters Multi-Program Strategic Collaboration
Dec 11 (Reuters) - Zealand Pharma A/S ZELA.CO: ZEALAND PHARMA AND OTR THERAPEUTICS ENTER MULTI-PROGRAM STRATEGIC COLLABORATION AND LICENSE AGREEMENT TO DEVELOP NOVEL THERAPEUTICS FOR METABOLIC DISEASES Source text: ID:nGNX4KwBs7 Further company coverage: ZELA.CO ((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Zealand Pharma A/S
See all newsZealand falls as Berenberg cuts to 'hold' on fading survodutide hopes
Europe Research Roundup: Aixtron, Lenzing, Novo Nordisk
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Focus: Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up